| Literature DB >> 23292147 |
Kana Kobayashi1, Koji Okihara, Tsuyoshi Iwata, Norihiro Aibe, Naohiro Kodani, Takuji Tsubokura, Kazumi Kamoi, Tsuneharu Miki, Hideya Yamazaki.
Abstract
Permanent prostate brachytherapy is frequently performed worldwide, and many studies have demonstrated its favorable outcomes. Implant seeds used in this procedure contain a precise amount of radionuclide and are completely sealed. Because these seeds are not manufactured in Japan, they are expensive (6300 yen per seed) and therefore need careful management as a radioisotope. The proper implantation technique requires considerable procedure time, good dosimetric outcomes and simple radioactive isotope management. To evaluate the modified hybrid interactive technique based on these considerations, we assessed 313 patients who underwent hybrid interactive brachytherapy without additional external beam radiotherapy. We evaluated the duration of the procedure, dosimetric factors and the total number of excess seeds. The dosimetric results from computed tomography on Day 30 of follow-up were: 172 Gy (range 130-194 Gy) for pD90, 97.8% (83.5-100%) for pV100, 54.6% (27.5-82.4%) for pV150, 164 Gy (120-220 Gy) for uD90, 194 Gy (126-245 Gy) for uD30, 210 Gy (156-290 Gy) for uD5, 0.02 ml (0-1.2 ml) for rV100 and 0 ml (0-0.2 ml) for rV150. The number of excess seeds was determined by subtracting the number of implanted seeds from the expected number of seeds calculated from previously proposed nomograms. As per our method, nine excess seeds were used for two patients, whereas using the nomograms, the number of excess seeds was approximately eight per patient. Our modified hybrid interactive technique reduced the number of excess seeds while maintaining treatment quality.Entities:
Keywords: I-125; excess seeds; hybrid interactive brachytherapy; prostate cancer
Mesh:
Year: 2013 PMID: 23292147 PMCID: PMC3650751 DOI: 10.1093/jrr/rrs126
Source DB: PubMed Journal: J Radiat Res ISSN: 0449-3060 Impact factor: 2.724
Patient characteristics
| Factor | Number or range |
|---|---|
| Age (median) | 45–80 (69) |
| i-PSA (median) ng/ml | 1.6–19.7 (6.8) |
| <10 | 213 |
| 10–20 | 100 |
| Gleason score | |
| 6 | 162 |
| 3 + 4 | 133 |
| Prostate volume (ml) | |
| <20 | 143 |
| 20–30 | 118 |
| >30 | 52 |
| Risk classification | |
| Low | 147 |
| Intermediate | 166 |
i-PSA = initial(before definite diagnosis) prostate specific antigen.
Fig. 1.Interactive procedure and real time dose coverage; interactive plan_2 (IP_2). Swelling prostate and adjust the seed position to the real implanted position. IP_2 could modify the excess seed in swelling prostate and adjust the seed position by the real implanted position. (a) According to the changing size and shape of prostate, IP_1 showed impossible seed position (outside the prostate and too close to the rectum). The seed might turn to be an excess seed. (b) Deletion of excess seed. (c) Search for other needle in which the seed could be deposited safely. (d) Changing plan by additional seed, and no extra seed.
Summary of studies of preplan and interactive techniques
| proceduretime(min) | D90 (Gy) | V100 (%) | V150 (%) | uD90 (Gy) | uD30 (Gy) | uD5 (Gy) | rV100 (ml) | rV150 (ml) | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Preplan | Gewanter (21) | 153 | 152 | 80 | NA | NA | NA | NA | NA | NA |
| Shanahan (6) | 122 | 132 | 86 | 51 | NA | NA | NA | NA | NA | |
| IOpre | Gewanter (21) | 150 | 137 | 83 | NA | NA | NA | NA | NA | NA |
| Wilkinson (24) | 40 | 137 | NA | NA | NA | NA | NA | NA | NA | |
| Kaplan (23) | 104 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Interactive | Zelfsky (7) | NA | 166 | 96 | 67 | NA | NA | NA | NA | NA |
| Beyer (22) | 57 | 152 | 94 | 49 | NA | NA | NA | NA | NA | |
| Beauieu institution 1 | 174 | 191 | 99 | 75 | NA | NA | NA | NA | NA | |
| Beauieu institution 2 | 167 | 196 | 100 | 73 | NA | NA | NA | NA | NA | |
| Hybrid interactive | Shanahan 6 | 45 | 157 | 94 | 42 | NA | NA | NA | NA | NA |
| Our study | 54 | 172 | 97 | 55 | 164 | 194 | 210 | 0.02 | 0 |
Adverse events (a) Acute adverse events
| CTCAE vers. 4 | Frequency | Retention | Pain | Incontinence | Hematuria | Proctitis | Rectal hemorrhage |
|---|---|---|---|---|---|---|---|
| 1 | 222 (71%) | 14 (4.5%) | 3 (1%) | 6 (2%) | 1 (0.3%) | 43 (4%) | 7 (2%) |
| 2 | 0 | 4 (1.2%) | 0 | 2 (0.6%) | 1 (0.3%) | 0 | 0 |
| 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| (b) Late adverse events | |||||||
| CTCAE vers. 4 | Frequency | Retention | Pain | Incontinence | Hematuria | Proctitis | Rectal hemorrhage |
| 1 | 15 (4.7%) | 8 (2.5%) | 17 (5.4%) | 6 (2%) | 1 (0.3%) | 1 (0.3%) | 4 (1.3%) |
| 2 | 0 | 2 (0.6%) | 0 | 2 (0.1%) | 1 (0.3%) | 0 | 2 (0.1%) |
| 3 | 0 | 1 (0.3%) | 0 | 0 | 0 | 0 | 0 |
Fig. 2.Comparison of proposed Nomogram to our actual seed ordering. (a) Mt. Sinai Lookup Table. We were able to conserve over 10 seeds in 22% of cases, over 5 seeds in 46% cases, while the estimated number of seeds proved to be insufficient in 4% of patients. (b) Anderson Nomogram. d avg = (AP + RL + SI)/3; d avg £ 3 cm: Actual total activity = 5.709 × d avg2; d avg > 3 cm: Actual total activity = 1.524 × d avg2. AP; anterio-posterior, RL; right-left, SI; superior-inferior. We were able to conserve over 10 seeds in 20% of cases, over 5 seeds in 43% cases, while the estimated number of seeds proved to be insufficient in 3% of patients.